Keith Lamont Cummings, CFO of Pliant Therapeutics PLRX, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $30.7K. The latest trade was on 04/17.

KC

KC

Keith Lamont Cummings

CFO

Company

Pliant Therapeutics PLRX

First filing

23/01/27

Trades

41 trades

Buys / sales

0 / 7

12-month net buying

−$30.7K

Last trade

04/17

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Pliant TherapeuticsPLRX	Open-market sale10b5-1 plan	01/20	01/22	24,002 sh	$1.28	$30,722.56	−7.5%
Pliant TherapeuticsPLRX	Open-market sale10b5-1 plan	25/01/17	25/01/22	20,148 sh	$11.20	$225,657.6	−7.1%
Pliant TherapeuticsPLRX	Open-market sale10b5-1 plan	24/07/10	24/07/12	10,911 sh	$11.56	$126,131.16	−3.7%
Pliant TherapeuticsPLRX	Open-market sale10b5-1 plan	24/01/17	24/01/19	9,781 sh	$17.23	$168,526.63	−4.8%
Pliant TherapeuticsPLRX	Open-market sale10b5-1 plan	23/07/17	23/07/19	19,771 sh	$18.01	$356,075.71	−8.8%
Pliant TherapeuticsPLRX	Open-market sale10b5-1 plan	23/03/30	23/04/03	9,960 sh	$26.52	$264,139.2	−6.3%
Pliant TherapeuticsPLRX	Open-market sale	23/01/23	23/01/25	30,000 sh	$35.00	$1,050,000	−26.2%